$8.76
0.091.04%
Last update: Nov 6, 8:59 AM
OptimizeRx Corp
OPRXNASDAQ
OptimizeRx (OPRX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
OptimizeRx (OPRX) last issued guidance on August 12, 2026 for fiscal year 2026. The company guided revenue in the range of $95M - $100M for the period.
Compared to prior guidance, OptimizeRx maintained its revenue forecast from a prior range of $95M - $100M.
OptimizeRx has issued 14 guidance updates between March 8, 2023 and August 12, 2026. During this period, the company raised its outlook 8 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.09 | $-0.02 | $0.18 | $-0.01 |
| Actual | $0.16 | $0.14 | $0.51 | $0.20 |
| Surprise | +77.8% | +800.0% | +183.3% | +2100.0% |
| Revenue | ||||
| Estimate | $20.3M | $18.4M | $31.2M | $23.7M |
| Actual | $20.5M | $19.8M | $32.2M | $26.1M |
| Surprise | +1.21% | +8.01% | +3.39% | +10.1% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.14 | $0.39 | $0.08 | $0.10 |
| Revenue | ||||
| Consensus | $21.2M | $34.6M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $0.16 | $0.09 | 77.8 % |
| Q1 | May 12, 2026 | $0.14 | $-0.02 | 800.0 % |
| Q4 | Mar 5, 2026 | $0.51 | $0.18 | 183.3 % |
| Q3 | Nov 6, 2025 | $0.20 | $-0.01 | 2100.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $20.50M | $20.26M | 1.21 % |
| Q1 | May 12, 2026 | $19.84M | $18.37M | 8.01 % |
| Q4 | Mar 5, 2026 | $32.24M | $31.18M | 3.39 % |
| Q3 | Nov 6, 2025 | $26.07M | $23.67M | 10.1 % |
